{"id":"W4309317789","doi":"10.25251/skin.6.supp.70","title":"Bimekizumab versus secukinumab continuous maintenance of response at every visit through one year in patients with moderate to severe plaque psoriasis: Post-hoc results from the BE RADIANT phase 3b trial","year":2022,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Secukinumab; Plaque psoriasis; Post-hoc analysis; Medicine; Post hoc; Psoriasis; Dermatology; Physical therapy; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002980166,0.00198136,0.004915291,0.0003736836,0.0005241345,0.00179575,0.001091446,0.00131872,0.005417789],"category_scores_gemma":[0.002068993,0.000759823,0.004748283,0.0004550325,0.001105832,0.001568813,0.000513241,0.004951417,0.001270597],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009677873,"about_ca_system_score_gemma":0.001005645,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001580206,"about_ca_topic_score_gemma":0.003003869,"domain_scores_codex":[0.9986839,0.000694389,0.00005952174,0.0002070649,0.00008882629,0.0002663352],"domain_scores_gemma":[0.9988041,0.0004168326,0.0002588472,0.000161556,0.00007577369,0.0002829619],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9845982,0.001648902,0.0005404797,0.0002712769,0.001828787,0.00002108866,0.0000298008,0.0004500752,0.0009975961,0.00005157102,0.0008249887,0.008737392],"study_design_scores_gemma":[0.9137617,0.07480934,0.006466656,0.00005450556,0.002542261,0.00004930041,0.00004920619,0.0007502682,0.0004110721,0.0002678604,0.0008104555,0.00002727942],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.985862,0.006630391,0.0005550745,0.0009848821,0.0006094273,0.0008313154,0.001479576,0.0001331513,0.002914072],"genre_scores_gemma":[0.9900252,0.002368212,0.0006195167,0.0009872864,0.0004700018,0.0008623079,0.001413542,0.00004584258,0.003208227],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005417789,"threshold_uncertainty_score":0.01812434,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01550826696414641,"score_gpt":0.2422494022651389,"score_spread":0.2267411353009925,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}